Literature DB >> 7619823

Microenvironments of basic amino acids in amphipathic alpha-helices bound to phospholipid: 13C NMR studies using selectively labeled peptides.

S Lund-Katz1, M C Phillips, V K Mishra, J P Segrest, G M Anantharamaiah.   

Abstract

The lipid-binding properties of serum apolipoproteins are mediated by class A amphipathic alpha-helices in which basic and acidic amino acid residues tend to be localized at the helix polar-nonpolar boundary and the center of the polar face, respectively. To better understand the role of the interfacial basic residues, the microenvironments and titration characteristics of lysine (Lys) residues have been examined using two 18-residue peptides. The parent 18A molecule (AspTrpLeuLysAlaPheTyrAspLysValAlaGluLysLeuLysGluAlaPhe) binds phospholipid relatively well because of its class A amphipathic helix, whereas 18R, which has the positions of basic and acidic residues reversed, binds to phospholipid relatively weakly. Lys residues were 13C-dimethylated, and NMR spectra were obtained of the peptides complexed with dimyristoylphosphatidylcholine (1/1 (w/w) DMPC/peptide). The four [13C]-epsilon-dimethyl-Lys in 18A gave four resonances at chemical shifts (delta) of 42-43 ppm, whereas only a single resonance at delta 42.70 ppm was observed from the four Lys in 18R. Measurements of delta as a function of pH gave pKa values. The four Lys in 18R had a common pKa of 10.3, indicating that the Lys in the polar face of the amphipathic helix have the pKa expected for noninteracting, fully hydrated groups. In contrast, the four Lys in Ac-18A-NH2 had pKa's in the range 9.4-11.0, indicating that they exist in various microenvironments at the polar-nonpolar boundary of the 18A helix. To examine individual Lys, 18A was synthesized with various Lys selectively labeled. Lys-4, -9, -13, and -15 in Ac-18A-NH2 associated with DMPC had pKa values of 11.0, 9.4, 9.4, and 10.3, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7619823     DOI: 10.1021/bi00028a035

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Sidedness of interfacial arginine residues and anti-atherogenicity of apolipoprotein A-I mimetic peptides.

Authors:  Gaurav Nayyar; Vinod K Mishra; Shaila P Handattu; Mayakonda N Palgunachari; Ronald Shin; David T McPherson; Champion C S Deivanayagam; David W Garber; Jere P Segrest; G M Anantharamaiah
Journal:  J Lipid Res       Date:  2012-02-29       Impact factor: 5.922

2.  Molecular dynamics on a model for nascent high-density lipoprotein: role of salt bridges.

Authors:  C Sheldahl; S C Harvey
Journal:  Biophys J       Date:  1999-03       Impact factor: 4.033

3.  Effect of cholesterol on bilayer location of the class A peptide Ac-18A-NH2 as revealed by fluorescence resonance energy transfer.

Authors:  Galyna Gorbenko; Tetsurou Handa; Hiroyuki Saito; Julian Molotkovsky; Masafumi Tanaka; Masashi Egashira; Minoru Nakano
Journal:  Eur Biophys J       Date:  2003-07-10       Impact factor: 1.733

4.  The membrane-binding properties of a class A amphipathic peptide.

Authors:  H Mozsolits; T-H Lee; A H A Clayton; W H Sawyer; M-I Aguilar
Journal:  Eur Biophys J       Date:  2003-07-18       Impact factor: 1.733

5.  Effect of leucine to phenylalanine substitution on the nonpolar face of a class A amphipathic helical peptide on its interaction with lipid: high resolution solution NMR studies of 4F-dimyristoylphosphatidylcholine discoidal complex.

Authors:  Vinod K Mishra; Mayakonda N Palgunachari; Rama Krishna; John Glushka; Jere P Segrest; G M Anantharamaiah
Journal:  J Biol Chem       Date:  2008-10-09       Impact factor: 5.157

6.  High-Resolution Structural Studies Elucidate Antiatherogenic and Anti-Inflammatory Properties of Peptides Designed to Mimic Amphipathic α-Helical Domains of Apolipoprotein A-I.

Authors:  Vinod K Mishra; Gattadahalli M Anantharamaiah
Journal:  Nat Prod Commun       Date:  2019-05-28       Impact factor: 1.496

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.